颅内自体脂肪移植分隔视交叉以改善立体定向放疗剂量学
本文报告2例(新诊断软骨肉瘤和再程放疗脑膜瘤)次全切除后肿瘤毗邻视交叉,通过开颅手术放置腹部脂肪自体移植物分隔肿瘤与危及器官,再行分次立体定向放疗;回顾性比较显示脂肪移植可降低视交叉及视神经最大剂量,同时维持肿瘤覆盖。
要点
- 脂肪自体移植可物理分隔肿瘤与视交叉,降低危及器官剂量。
- 软骨肉瘤病例视交叉最大剂量降低21%(70.4 Gy降至55.3 Gy)。
- 再程放疗脑膜瘤病例视交叉最大剂量降低10%(50.8 Gy降至45.9 Gy)。
核心结论
- 腹部脂肪自体移植可最大化肿瘤覆盖的同时最小化颅内危及器官剂量。
研究设计与样本
- 病例报告,共2例:新诊断软骨肉瘤和既往放疗后脑膜瘤,均行次全切除后肿瘤毗邻视交叉。
主要发现
- 软骨肉瘤:脂肪移植使视交叉最大剂量降低21%(70.4 Gy降至55.3 Gy)。
- 再程放疗脑膜瘤:视交叉最大剂量降低10%(50.8 Gy降至45.9 Gy),左侧视神经降低17%(48.9 Gy降至40.4 Gy),右侧视神经降低30%(32.3 Gy降至22.6 Gy)。
临床怎么用
- 对于次全切除后肿瘤毗邻视交叉、 definitive 放疗可能损伤视路或肿瘤覆盖不足者,可考虑开颅放置腹部脂肪自体移植物后行分次立体定向放疗。
局限性
- 回顾性病例报告,仅2例,样本量小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiation therapy for intracranial lesions is constrained by dose to neurologic organs at risk. CASE DESCRIPTION: We report 2 cases, a newly diagnosed chondrosarcoma and a previously irradiated meningioma, with tumors that abutted the optic chiasm following subtotal resection. Definitive radiotherapy would have required either undercoverage of the tumor or treatment of the chiasm with doses posing an unacceptable risk of blindness. Therefore, the patients underwent open surgery with placement of an abdominal fat autograft to provide space between the tumor and the optic structures at risk. Patients received definitive fractionated stereotactic radiotherapy. For each patient, we retrospectively compared the treated plan (with fat autograft) to a second plan generated using the pre-autograft imaging, maintaining similar tumor coverage. For the chondrosarcoma, the fat autograft reduced the optic chiasm maximum dose by 21% (70.4 Gy to 55.3 Gy). For the reirradiated peri-optic meningioma, the optic chiasm maximum dose was reduced by 10% (50.8 Gy to 45.9 Gy), the left optic nerve by 17% (48.9 Gy to 40.4 Gy), and the right optic nerve by 30% (32.3 Gy to 22.6 Gy). CONCLUSIONS: We demonstrate the utility of abdominal fat autograft placement to maximize coverage of tumor while minimizing dose to intracranial organs at risk.
引用
- Turner BE, Schüler E, Chang SD, et al. Intracranial Autograft Fat Placement to Separate the Optic Chiasm from Tumor to Improve Stereotactic Radiotherapy Dosimetry. World Neurosurg. 2020. PMID: 33130141. doi:10.1016/j.wneu.2020.10.110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。